Ten years of optimizing outcomes for women with type 1 and type 2 diabetes in pregnancy - The Atlantic DIP experience

Journal of Clinical Endocrinology and Metabolism

Volumn 101, Issue 4, 2016, Pages 1598-1605

  Owens, Lisa A ^a,b   Egan, Aoife M ^a,b   Carmody, Louise ^a,b   Dunne, Fidelma ^a,b  

^a Atlantic Diabetes in Pregnancy Programme   (Ireland)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; CONGENITAL MALFORMATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; GESTATIONAL WEIGHT GAIN; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT EDUCATION; PRACTICE GUIDELINE; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; RETROSPECTIVE STUDY; STILLBIRTH; CONGENITAL ABNORMALITIES; INCIDENCE; IRELAND; NEWBORN; PATHOPHYSIOLOGY; PRE-ECLAMPSIA; PREGNANCY; PRENATAL CARE;

ADULT; CONGENITAL ABNORMALITIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFANT, NEWBORN; IRELAND; MATERNAL AGE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY OUTCOME; PRENATAL CARE; RETROSPECTIVE STUDIES; STILLBIRTH;

EID: 85011294843     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-3817     Document Type: Article

References (45)

1. Murphy HR, Roland JM, Skinner TC, et al. Effectiveness of a regional prepregnancy care program in women with type 1 and type 2 diabetes: benefits beyond glycemic control. Diabetes Care. 2010;33(12):2514-2520.
2. Wahabi HA, Alzeidan RA, Bawazeer GA, Alansari LA, Esmaeil SA. Preconception care for diabetic women for improving maternal and fetal outcomes: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2010;10:63.
3. Kitzmiller JL, Wallerstein R, Correa A, Kwan S. Preconception care for women with diabetes and prevention of major congenital malformations. Birth Defects Res A Clin Mol Teratol. 2010;88:791-803.
4. Rosenn B, Miodovnik M, Combs CA, Khoury J, Siddiqi TA. Preconception management of insulin-dependent diabetes: improvement of pregnancy outcome. Obstet Gynecol. 1991;77:846-849.
5. Fuhrmann K, Reiher H, Semmler K, Fischer F, Fischer M, Glöckner E. Prevention of congenital malformations in infants of insulin-dependent diabetic mothers. Diabetes Care. 1983;6:219-223.
6. Willhoite MB, Bennert HW Jr, Palomaki GE, et al. The impact of preconception counseling on pregnancy outcomes. The experience of the Maine Diabetes in Pregnancy Program. Diabetes Care. 1993;16:450-455.
7. Steel JM, Johnstone FD, Hepburn DA, Smith AF. Can prepregnancy care of diabetic women reduce the risk of abnormal babies? BMJ. 1990;301:1070-1074.
8. Temple RC, Aldridge VJ, Murphy HR. Prepregnancy care and pregnancy outcomes in women with type 1 diabetes. Diabetes Care. 2006;29:1744-1749.
9. Correa A, Gilboa SM, Botto LD, et al. Lack of periconceptional vitamins or supplements that contain folic acid and diabetes mellitus-associated birth defects. Am J Obstet Gynecol. 2012;206:218.e1-e13.
10. Oyama K, Sugimura Y, Murase T, et al. Folic acid prevents congenital malformations in the offspring of diabetic mice. Endocr J. 2009;56:29-37.
11. Pregnancy outcomes in the Diabetes Control and Complications Trial. Am J Obstet Gynecol. 1996;174:1343-1353.
12. Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ. 2004;328:915.
13. Persson M, Norman M, Hanson U. Obstetric and perinatal outcomes in type 1 diabetic pregnancies: A large, population-based study. Diabetes Care. 2009;32:2005-2009.
14. Jensen DM, Korsholm L, Ovesen P, et al. Peri-conceptional A1C and risk of serious adverse pregnancy outcome in 933 women with type 1 diabetes. Diabetes Care. 2009;32:1046-1048.
15. Middleton P, Crowther CA, Simmonds L. Different intensities of glycaemic control for pregnant women with pre-existing diabetes. Cochrane Database Syst Rev. 2012;8:CD008540.
16. Jovanovic L, Druzin M, Peterson CM. Effect of euglycemia on the outcome of pregnancy in insulin-dependent diabetic women as compared with normal control subjects. Am J Med. 1981;71:921-927.
17. Jensen DM, Damm P, Moelsted-Pedersen L, et al. Outcomes in type 1 diabetic pregnancies: a nationwide, population-based study. Diabetes Care. 2004;27:2819-2823.
18. Egan AM, Dennedy MC, Al-Ramli W, Heerey A, Avalos G, Dunne F. ATLANTIC-DIP: excessive gestational weight gain and pregnancy outcomes in women with gestational or pregestational diabetes mellitus. J Clin Endocrinol Metab. 2014;99:212-219.
19. Hillier TA, Pedula KL, Vesco KK, et al. Excess gestational weight gain: modifying fetal macrosomia risk associated with maternal glucose. Obstet Gynecol. 2008;112:1007-1014.
20. Scifres CM, Feghali MN, Althouse AD, Caritis SN, Catov JM. Effect of excess gestational weight gain on pregnancy outcomes in women with type 1 diabetes. Obstet Gynecol. 2014;123:1295-1302.
21. Dunne FP, Avalos G, Durkan M, et al. ATLANTIC DIP: pregnancy outcome for women with pregestational diabetes along the Irish Atlantic seaboard. Diabetes Care. 2009;32(7):1205-1206.
22. Owens LA, Avalos G, Kirwan B, Carmody L, Dunne F. ATLANTIC DIP: closing the loop: a change in clinical practice can improve outcomes for women with pregestational diabetes. Diabetes Care. 2012;35(8):1669-1671.
23. The Saint Vincent Declaration on diabetes care and research in Europe. Acta Diabetol. 1989;10(suppl):143-144.
24. Health Pricing Office, Health Service Executive. Perinatal Statistics Report, 2013. http://www.hse.ie/eng/services/publications/Perinatal-Statistics-Report-2013.pdf. Published December 2014. Accessed January 4, 2015.
25. Jensen DM, Korsholm L, Ovesen P, et al. Peri-conceptional A1C and risk of serious adverse pregnancy outcome in 933 women with type 1 diabetes. Diabetes Care. 2009;32:1046-1048.
26. Tennant PW, Glinianaia SV, Bilous RW, Rankin J, Bell R. Pre-existing diabetes, maternal glycated haemoglobin, and the risks of fetal and infant death: a population-based study. Diabetologia. 2014;57(2):285-294.
27. Maresh MJ, Holmes VA, Patterson CC, et al. Glycemic targets in the second and third trimester of pregnancy for women with type 1 diabetes. Diabetes Care. 2015;38:34-42.
28. Jovanovic L, Peterson CM. Insulin and glucose requirements during the first stage of labor in insulin-dependent diabetic women. Am J Med. 1983;75:607-612.
29. National Institute for Health and Care Excellence. Diabetes in pregnancy: management from preconception to the postnatal period. NICE Guidelines (NG3). nice.org.uk/guidance/ng3. Published February 2015. Accessed September 2, 2015.
30. American Diabetes Association. Standards of medical care in diabetes-2015. Diabetes Care. 2015;38(suppl 1):S1-S94.
31. American Diabetes Association. Management of diabetes in pregnancy. Diabetes Care. 2015;38(suppl 1):S77-S79.
32. Egan AM, McVicker L, Heerey A, Carmody L, Harney F, Dunne FP. Diabetic retinopathy in pregnancy: a population-based study of women with pregestational diabetes. J Diabetes Res. 2015;2015:310239.
33. Coetzee EJ, Jackson WP. Metformin in management of pregnant insulin-independent diabetics. Diabetologia. 1979;16:241-245.
34. Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev. 2010;1:CD003053.
35. Gutzin SJ, Kozer E, Magee LA, Feig DS, Koren G. The safety of oral hypoglycemic agents in the first trimester of pregnancy: a meta-analysis. Can J Clin Pharmacol. 2003;10:179-183.
36. Gilbert C, Valois M, Koren G. Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis. Fertil Steril. 2006;86:658-663.
37. Gui J, Liu Q, Feng L. Metformin vs insulin in the management of gestational diabetes: a meta-analysis. PLoS One. 2013;8(5):e64585.
38. Rowan JA, Hague WM, Gao W, Battin MR, Moore MP. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med. 2008;358:2003-2015.
39. Rowan JA, Rush EC, Obolonkin V, Battin M, Wouldes T, Hague WM. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition at 2 years of age. Diabetes Care. 2011;34:2279-2284.
40. Simmons D, Jelsma JG, Galjaard S, et al. Results from a European multicenter randomized trial of physical activity and/or healthy eating to reduce the risk of gestational diabetes mellitus: the DALI lifestyle pilot. Diabetes Care. 2015;38:1650-1656.
41. Chiswick C, Reynolds RM, Denison F, et al. Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2015;3:778-786.
42. Takoudes TC, Weitzen S, Slocum J, Malee M. Risk of cesarean wound complications in diabetic gestations. Am J Obstet Gynecol. 2004;191:958-963.
43. Ehrenberg HM, Durnwald CP, Catalano P, Mercer BM. The influence of obesity and diabetes on the risk of cesarean delivery. Am J Obstet Gynecol. 2004;191:969-974.
44. Cardwell CR, Stene LC, Joner G, et al. Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of observational studies. Diabetologia. 2008;51:726-735.
45. Thavagnanam S, Fleming J, Bromley A, Shields MD, Cardwell CR. A meta-analysis of the association between Caesarean section and childhood asthma. Clin Exp Allergy. 2008;38:629-633.